Interferon-beta or azathioprine as add-on therapies in patients with active multiple sclerosis
Veronika Ticha, Tomas Kalincik, Eva Havrdova
Neurological Research | MANEY PUBLISHING | Published : 2012
Awarded by Czech Ministry of Education
Veronika Ticha received compensation for travel and honoraria from Novartis, Teva a Merck-Serono. Tomas Kalincik received compensation for travel and honoraria from Biogen Idec, Novartis, Sanofi Aventis, Teva and Merck Serono. Eva Havrdova received speaker honoraria and consulting fees from Biogen Idec, Merck Serono, Novartis, Genzyme and Teva, as well as support for research activities from Biogen Idec and Merck Serono.The authors thank the subjects who participated in this study. This work was supported by the Czech Ministry of Education (MSM 0021620849).